Cidara Therapeutics And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Cidara Therapeutics And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by around 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯週一收高了約 200 點。當內部人士購買或出售股票時，表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以認為這是他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是最近一些細價股的著名內幕交易。欲了解更多信息，請查看 本辛加的內幕交易 平台。
Cidara Therapeutics
西達拉治療
- The Trade: Cidara Therapeutics, Inc. (NASDAQ:CDTX) President and CEO Jeffrey Stein acquired a total 50,000 shares an average price of $1.04. To acquire these shares, it cost around $51.85 thousand.
- What's Happening: Cidara Therapeutics reported worse-than-expected Q4 EPS and sales results.
- What Cidara Therapeutics Does: Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases.
- 貿易： 賽達拉治療, 公司. (納斯達克:CDTX) 總裁兼首席執行官杰弗裡·斯坦 購入總共 5 萬股 平均價格為 1.04 美元。要收購這些股票，其成本約為 51.85 萬美元。
- 發生了什麼事： 賽達拉治療學報告的第四季度每股收益和銷售結果差於預期。
- 什麼賽達拉治療是否: 西達拉治療公司是一家生物技術公司。它專注於新型抗感染藥的發現，開發和商業化，用於治療和預防疾病。
Heliogen
氦气原
- The Trade: Heliogen, Inc. (NYSE:HLGN) 10% owner Patrick Soonshiong acquired a total of 1,334,051 shares at an average price of $0.23. The insider spent around $306.2 thousand to buy those shares. The company's VP, CFO and Treasurer also purchased the company's shares.
- What's Happening: Heliogen is expected to release financial and operating results for the fourth quarter on Tuesday, March 28, 2023.
- What Heliogen Does: Heliogen Inc is a concentrated solar energy system that is being developed to unlock the power of sunlight to replace fossil fuels.
- 貿易: 赫利奥根股份有限公司 紐約證券交易所代碼:HLGN) 10% 擁有者派翠克·宋雄 購入本公司合共股份 平均價格為 0.23 美元。內部人士花費了大約 306.2 萬美元購買這些股票。該公司的副總裁，首席財務官和財務官還購買了該公司的股票。
- 發生了什麼：預計赫利奧根將於 2023 年 3 月 28 日（星期二）公布第四季度財務和經營業績。
- 什麼日昇作用: Heliogen Inc 是一種集中太陽能系統，正在開發用於釋放太陽能以取代化石燃料的能量。
Check This Out: Investor Fear Eases As Dow Jumps Around 200 Points
看看這個： 道指指在 200 點附近跳動，投資者恐懼放緩
Texas Mineral Resources
德州礦產資源
- The Trade: Texas Mineral Resources Corp. (OTC:TMRC) Director Anthony Marchese acquired a total of 21,364 shares at an average price of $1.43. To acquire these shares, it cost around $30.54 thousand.
- What's Happening: The company's stock tumbled around 39% over the past six months.
- What Texas Mineral Resources Does: Texas Mineral Resources Corp is an exploration-stage mining company. It is primarily engaged in the business of acquisition, exploration, and development of mineral properties.
- 貿易: 德州礦產資源公司 (OTC: TMRC) 董事安東尼·馬凱斯 購入總共二十一萬三百六十四股股份 平均價格為 1.43 美元。要收購這些股票，它的成本約為 30.54 萬美元。
- 發生了什麼：在過去六個月中，該公司的股票下跌了 39％ 左右。
- 德州礦產資源做什麼: 德州礦產資源股份有限公司是一家探索階段的礦業公司。它主要從事收購，勘探和礦產物業的開發業務。
Don't forget to check out our premarket coverage here
不要忘記在這裡查看我們的售前覆蓋範圍
譯文內容由第三人軟體翻譯。